Latest filing published 03 Sept 2026 for Moderna, Inc., €93k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Shannon Thyme Klinger is a declared insider at 2 companies (senior executive); the most frequent names are Moderna, Inc. and Rafael Holdings, Inc. The record holds 54 filings, for trades running from 5 January 2022 to 4 September 2026.
No open-market purchase appears, only 1 sale worth €418k. The rest of the record consists of 9 share grants and 44 option exercises. In 2026 alone, the filings show no purchases and 1 sale.
The newest entry dates from 8 September 2026: an option exercise, in Moderna, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 52 declarations